CCR9 and hepatocellular carcinoma: Studies have revealed that ectopic expression of CCR9 may be mediated by the downregulation of p21 and p27 and upregulation of cyclin D1 to enhance cell proliferation and tumorigenicity in hepatocellular carcinoma cells.